Associate Director, Program Manager

The role

This person will lead integrated planning and execution for a clinical-stage program. They will partner with cross-functional teams to deliver program milestones and build program management capabilities.

What you will do

• Develop and maintain integrated development plans, timelines, milestones, risks, and scenarios
• Own core planning documents including integrated timeline, risk plan, dashboards, and status updates
• Serve as central point of contact for issue identification, resolution, and escalation
• Facilitate program team and subteam meetings
• Support the Program Leader in delivering updates to the Executive Leadership Team
• Support cross-functional resource, budget, and capacity planning
• Build and maintain the program's document-sharing environment
• Champion program management best practices

Required qualifications

• 8+ years of pharmaceutical or biotech industry experience
• 3+ years in program, portfolio, or alliance management
• BA/BS in a scientific, engineering, business, or related discipline
• Direct experience working with Clinical Development, Clinical Operations, Regulatory, Technical Operations (CMC), and Nonclinical Development
• Working knowledge of the drug discovery, development, and commercialization process
• Track record of guiding cross-functional teams through complex scientific, regulatory, and development challenges
• Ability to influence without direct authority
• Strong analytical and problem-solving skills
• Excellent written and verbal communication
• Ability to manage multiple priorities in a fast-paced, high-visibility environment
• Proficiency in Smartsheet

Nice to have

• Advanced degree (PhD, MS, MBA)
• Neuroscience or neuropsychiatric development experience
• Experience with enterprise PPM tools (e.g., Microsoft Project, Planisware, Planview)
• Experience with AI LLM tools

About the company

Seaport Therapeutics is a clinical-stage therapeutics company advancing the development of novel neuropsychiatric medicines. The company uses its proprietary GlyphTM technology platform to advance clinically validated mechanisms.